Pancreatic Cancer in China
Overview
Pancreatic cancer — usually ductal adenocarcinoma — is aggressive and frequently diagnosed late. Outcomes depend strongly on treatment at experienced high-volume centers where surgery, pathology and oncology are tightly integrated.
China’s major pancreatic centers perform very high volumes of Whipple procedures and have pioneered neoadjuvant strategies that convert borderline tumors to resectable ones.
Symptoms & Signs
Painless jaundice: yellowing of skin and eyes, dark urine and pale stools
Upper abdominal pain boring through to the back
Unexplained weight loss and new-onset diabetes in older adults
Loss of appetite, fatigue and nausea
New or worsening depression occasionally preceding diagnosis
Steatorrhea — greasy, floating stools — from enzyme insufficiency
Diagnosis
Pancreas-protocol contrast CT defining vessel involvement and resectability
MRI/MRCP mapping the bile and pancreatic ducts
Endoscopic ultrasound (EUS) with fine-needle biopsy for tissue confirmation
CA19-9 tumor marker for prognosis and monitoring
Genetic profiling including BRCA and MSI to guide therapy
Diagnostic laparoscopy excluding occult peritoneal spread
Treatment Options
Whipple pancreaticoduodenectomy — the definitive operation for head tumors — at high-volume centers
Distal pancreatectomy for body and tail tumors, increasingly laparoscopic or robotic
Neoadjuvant chemotherapy converting borderline tumors to resectable status
FOLFIRINOX or gemcitabine-based chemotherapy for advanced disease
Precision radiotherapy (SBRT) for locally advanced tumors and pain control
Early integration of pain management, nutrition and pancreatic-enzyme support
Advanced Technologies & Novel Drug
Robotic and laparoscopic Whipple procedures with low complication rates
ICG fluorescence navigation during pancreatic surgery
ERAS recovery protocols after major pancreatic resection
SBRT and adaptive radiotherapy targeting locally advanced tumors
Novel second-line chemotherapy and targeted agents accessible through major-center programs
Hospital & Specialist
- Cancer Hospital, Chinese Academy of Medical Sciences (CICAMS) — Beijing
- Zhongshan Hospital, Fudan University — Shanghai
- Sun Yat-sen University Cancer Center (SYSUCC) — Guangzhou
- West China Hospital, Sichuan University (Huaxi Hospital) — Chengdu
- Yang Yin Mo — Hepatobiliary and Pancreatic Surgery
- Li Jie — GI Oncology
- Bi Xin Yu — Hepatobiliary Surgery
- Wang Li Ming — Hepatobiliary Surgery